Re: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia

scientific article published on August 2008

Re: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2008-04-150870
P932PMC publication ID2481535
P698PubMed publication ID18650464
P5875ResearchGate publication ID51424056

P2093author name stringIan J Cohen
P2860cites workIn vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileQ28472573
Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous systemQ35763862
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group studyQ42542470
Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexateQ48117441
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexateQ48442432
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.Q52921493
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione ItaQ52966055
How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemiaQ67902968
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group studyQ70697030
High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemiaQ80313380
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmethotrexateQ422232
P304page(s)910
P577publication date2008-08-01
P1433published inBloodQ885070
P1476titleRe: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia
P478volume112

Search more.